Medica’s potential made clear at markets day says broker


Medica Group PLC (LSE:MGP, FRA:2MI)’s capital markets day underlined why it is confident in delivering double-digit sales and profit growth in the medium term said Liberum.

The broker, which has a target price of 235p, said the company’s core market of Teleradiology is capacity constrained and seeing accelerating demand.

Medica’s strategy, therefore, of building an international network of teleradiologists, coupled with an efficient technology platform, means it is ideally placed to tap this demand and hit its growth targets.

Liberum expects 14% sales growth and 22% earnings growth in the medium term, which isn’t reflected in the forward earnings multiple of 18 times.

Buy is its investment view

Shares rose 1.2% to 167p.


Please enter your comment!
Please enter your name here